Thompson Davis & Co., Inc. Arrowhead Pharmaceuticals, Inc. Transaction History

Thompson Davis & Co., Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$58.09 - $82.51 $166,776 - $236,886	-2,871 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$14.0 - $20.3 $79,548 - $115,344	-5,682 Reduced 66.43%	2,871 $55,000
Q2 2018 Aug 03, 2018	SELL	$6.37 - $14.02 $21,759 - $47,892	-3,416 Reduced 28.54%	8,553 $116,000
Q1 2018 May 02, 2018	BUY	$3.72 - $7.64 $22,535 - $46,283	6,058 Added 102.49%	11,969 $86,000
Q4 2017 Feb 05, 2018	BUY	$3.14 - $4.5 $18,560 - $26,599	5,911	5,911 $22,000

296

88.5M

905K

387K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.71B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Thompson Davis & Co., Inc. with notifications on news.